A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients ; volume:11 ; number:1 ; day:14 ; month:1 ; year:2021 ; pages:1-8 ; date:12.2021
Scientific reports ; 11, Heft 1 (14.1.2021), 1-8, 12.2021
- Creator
-
Xiao, Juan
Yun, Canhua
Cao, Jingjia
Ding, Shouluan
Shao, Chunchun
Wang, Lina
Huang, Fengyan
Jia, Hongying
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-80015-8
- URN
-
urn:nbn:de:101:1-2021020823535353830663
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xiao, Juan
- Yun, Canhua
- Cao, Jingjia
- Ding, Shouluan
- Shao, Chunchun
- Wang, Lina
- Huang, Fengyan
- Jia, Hongying
- SpringerLink (Online service)
Other Objects (12)
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule